(Part 3 of 6) Substance Use Disorder: Initiating Buprenorphine in the Fentanyl Era and Other Treatment Considerations in Patients With Opioid Use Disorder and HIV
Overview Assessment of Needs Substance use disorder, including the misuse of opioids, may disproportionately affect people with HIV. It is essential that clinicians who treat patients with HIV recognize the signs of opioid use disorder and understand the current treatment options and challenges. Drug Enforcement Agency certificate holders are now required to complete 8 (more…)
Cardiovascular Disease Prevention in Patients With HIV: The REPRIEVE Trial
Overview Assessment of Needs The primary results of the REPRIEVE (Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults) trial were published in the New England Journal of Medicine in July 2023 and show that the statin drug pitavastatin calcium lowers the risk of heart disease in people (more…)
Respiratory Syncytial Virus and Influenza Infections: New Immunization Approaches for Children
Overview Assessment of Needs Respiratory syncytial virus (RSV) and influenza are viruses associated with high mortality in children. Children at risk include the very young (<2 years of age) and those with immunocompromising conditions, such as HIV. This webinar, led by Yvonne Maldonado, MD, will discuss the latest science and recommendations for the prevention (more…)
HIV 101: Initial Assessment, Initiation of Antiretroviral Therapy, and Monitoring of People With Newly Diagnosed HIV
Overview Assessment of Needs A firm grasp of the basics of clinical care for patients with HIV is essential for practitioners in Ryan White HIV/AIDS-funded clinics and programs who are new to HIV care. In this webinar, experts in the field will describe the core principles of HIV management, including (more…)
(Part 4 of 6) Substance Use Disorder: Alcohol and Tobacco Use Disorders in Patients With HIV
Overview Assessment of Needs Substance use disorders, including alcohol and tobacco use disorders, may disproportionately affect people with HIV. It is essential that clinicians who treat patients with HIV recognize the signs of alcohol and tobacco use disorder and understand the current treatment options and challenges. Drug Enforcement Agency certificate holders are now required (more…)
(Part 5 of 6) Substance Use Disorder: Stimulant Use Disorder, Harm Reduction, and Contingency Management in Patients With HIV
Overview Assessment of Needs Substance use disorders, including stimulant use disorders, may disproportionately affect people with HIV. It is essential that clinicians who treat patients with HIV recognize the signs of stimulant use disorder and understand the current treatment options and challenges. Drug Enforcement Agency certificate holders are now required to complete 8 hours (more…)